Connect with us

INDUSTRIAL HEMP

Cannabis Science Inc (OTCMKTS:CBIS) Erodes Its Gains

Published

on

In the last trading session, the stock price of Cannabis Science Inc (OTCMKTS:CBIS) declined more than 4% to close the day at $0.114. The decline came at a share volume of 62.95 million compared to average share volume of 23.41 million.

The buzz

Cannabis Science expressed that it supports the U.S. Federal Government, and the firm plans to step in with its professionals to help the Federal Government. The firm is looking to advance new Federal marijuana policy and requests Department of Justice to help formulate a properly-controlled Federal Policy for patients’ safe access to pharmaceutical as well as pharmacy dispensed cannabinoids for several critical diseases.

Cannabis Science has introduced numerous measures to study the application of cannabinoid-based drugs. For one such measure, initial results on utilizing nanoparticle drones to aim and successfully kill Stage IV lung cancer cells with cannabinoids and radiosensitizers have been posted in the cancer research journal “Frontiers in Oncology.”

This publication of their work has clearly documented their success in a one of the major Oncology publications as proof of their cannabinoid research expertise. Nanoparticle drones to aim lung cancer with cannabinoids and radiosensitizers, addresses drug delivery, and showcases an innovative plan to offer cannabinoids directly to cancer cells with marginal side effects or toxicities that have so far loaded clinical translation initiatives.

Equally significant, Cannabis Science boasts the grit in the market: it has been received and registered its preliminary Federal CAGE Code clearance back in 2009. The company is one of the only firms in its market with the ability to associate directly with the U.S. Federal Government. It plans to use its vast expertise and relationships within its team from several Government Agencies, Government Medical Research, University Medical Research, Pharmacy Dispensing, Pharmaceutical Drug Development and several other major points on this matter.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement